National Institute for Health and Clinical Excellence (NICE)
NICE publishes first rapid COVID-19 guidelines
New guidelines cover the management of patients in critical care, the management of patients who are having kidney dialysis and the management of patients who are receiving systemic anticancer treatments.
NICE has published its first 3 rapid guidelines on the care of people with suspected and confirmed COVID-19, and in patients without COVID-19.
These guidelines have been developed to maximise patient safety whilst making the best use of NHS resources and protecting staff from infection. The guideline has been developed using the interim process and methods for developing rapid guidelines on COVID-19 and recommendations are based on evidence and expert opinion.
COVID-19 rapid guideline: critical care
The guideline on critical care says that all patients on admission to hospital, irrespective of COVID-19 status, should continue to be assessed for frailty using a recognised frailty score (for example, the Clinical Frailty Scale [CFS]).
It also says the risks and benefits and likely outcomes should be discussed with patients, carers or advocates and families using decision support tools (where available) so that they can make informed decisions about their treatment wherever possible.
For patients with confirmed COVID-19, the guideline says decisions about admission to critical care should be made on the basis of medical benefit, taking into account the likelihood that the person will recover to an outcome that is acceptable to them and within a period of time consistent with the diagnosis.
COVID-19 rapid guideline: delivery of systemic anticancer treatments
The rapid guideline on the delivery of systemic anticancer treatments says that where decisions need to be made about prioritising patients for treatment, these need to take into account the level of immunosuppression associated with individual treatments and cancer types, and any other patient-specific risk factors. They should also balance the risk from cancer not being treated optimally versus the risk of becoming seriously ill if they contract COVID-19 because of immunosuppression.
Where changes need to be made to usual care because of system pressures, the guideline says consideration should be given to delivering treatment in different and less immunosuppressive regimens, different locations or via another route of administration.
COVID-19 rapid guideline: dialysis service delivery
The guideline on dialysis says that patients with suspected COVID-19 should be assessed to see whether dialysis could be delayed until their COVID-19 status is known. It also recommends that that outpatient transport services should get patients to their dialysis as scheduled to avoid their condition deteriorating, It should also be ensured that appropriate transport services are available by finding out what current transport providers are prepared to provide, and whether there are alternative providers if the current providers will not transport patients infected with COVID-19.
Further guidelines will be announced in due course but are likely to include: symptom management; patients receiving radiotherapy; and patients with rheumatoid arthritis. NICE will publish new guidelines each week until the full set has been completed, based on the priorities for patients and the NHS.
The guidelines are being produced in collaboration with NHS England/Improvement and a cross-specialty clinical group, supported by the specialist societies and Royal Colleges. NICE will make the guidelines accessible on its website so that health systems around the world can see the approach the UK is taking.
Latest News from
National Institute for Health and Clinical Excellence (NICE)
Patients with rare bile duct cancer set to benefit from life extending treatment22/07/2021 13:15:00
Some people who have a rare form of bile duct cancer are set to benefit from life-extending treatment
A new approach to prioritising requests for NICE Scientific Advice19/07/2021 14:15:00
Dr Jacoline Bouvy explains the new NICE Advice prioritisation process.
NICE to produce rapid guideline to diagnose and treat rare blood clotting condition associated with COVID-19 vaccination09/07/2021 13:25:00
NHS England has asked NICE to develop a guideline on the management and follow up of blood clots and low platelet counts associated with COVID-19 vaccination.
NICE opens consultation on draft pelvic floor dysfunction guideline recommendations30/06/2021 14:15:00
NICE recently (28 June 2021) published its draft guideline on the prevention and non-surgical management of pelvic floor dysfunction and is seeking stakeholder comments on the draft recommendations.
NICE recommends adoption of absorbable stitches with antibacterial protection for use on the NHS29/06/2021 11:15:00
NICE estimates an average cost saving of £13.62 per patient to the NHS as a result of reduced surgical site infections compared with current standard absorbable stitches.
Consider mental health support for some people with acne, says NICE25/06/2021 15:05:00
In final guidance published today (25 June), NICE has for the first time recommended mental health support for people who are severely affected by their acne
NICE and PHE publish comprehensive draft guideline to tackle the health burden of smoking25/06/2021 12:15:00
Healthcare staff should give clear and up-to-date information on e-cigarettes to people who are interested in using them to stop smoking, according to draft NICE guideline recommendations out for consultation today. NICE worked with Public Health England to develop this guideline
Shared decision making underpins good healthcare18/06/2021 11:15:00
Shared decision making between service users and healthcare professionals is an integral part of healthcare, says NICE, in new guideline recommendations published yesterday.
Shared decision making recommendations will ensure people are at the heart of healthcare18/06/2021 08:15:00
NICE’s new guideline on shared decision making will help transform people’s experiences of health and social care. It will instil greater collaboration between professionals, patients and their families. It will pioneer a new climate and culture of putting people firmly at the heart of our healthcare system.